Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content
Abstract Background Circulating cell-free DNA (cfDNA) in the plasma of cancer patients contains cell-free tumour DNA (ctDNA) derived from tumour cells and it has been widely recognized as a non-invasive source of tumour DNA for diagnosis and prognosis of cancer. Molecular profiling of ctDNA is often...
Main Authors: | Devika Ganesamoorthy, Alan James Robertson, Wenhan Chen, Michael B. Hall, Minh Duc Cao, Kaltin Ferguson, Sunil R. Lakhani, Katia Nones, Peter T. Simpson, Lachlan J. M. Coin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-09160-1 |
Similar Items
-
CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy
by: Sonia Mayo, et al.
Published: (2022-04-01) -
The emerging clinical relevance of genomic profiling in neuroendocrine tumours
by: Guney Isa Burak, et al.
Published: (2021-03-01) -
Liquid Biopsies: Emerging role and clinical applications in solid tumours
by: Sandeep Sisodiya, et al.
Published: (2023-09-01) -
Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients
by: Uršula Prosenc Zmrzljak, et al.
Published: (2021-02-01) -
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
by: Young Seok Ju, et al.
Published: (2014-10-01)